李氏大药厂
港股通 官网
( 00950.hk)
市盈率7.75市净率0.35股息率3.72% (3.72%) 上市时间2002-07-15股价1.21港币涨跌幅-2.42%成交金额48.55万港币换手率0.07%市值7.12亿港币H股市值7.12亿港币总股本5.89亿H股本5.89亿每手股数500上市至今年化投资收益率6.51%港股通持仓占H股比例0.04% (29.28万港币2026-03-31)
所属三级行业药品 (恒生) 市盈率28.84市净率2.88股息率1.24% (1.31%) 恒生:医疗保健业药品及生物科技药品
备注 (1): 双击编辑备注
发表讨论

李氏大药厂(00950) - 最新股东

*注解:(L)- 好仓, (S)- 淡仓, (P)- 可供借出的股份。
全部董事非董事
股东名称持有权益的股份数目占已发行的有投票权股份百分比占股本比例最后申报有关通知之日期表格序号
Sigma Tau Finanziaria S.p.A. (the surviving company after the merger with Sigma Tau International S.A.)
1.42亿 (L)
25.75% (L)
24.12%2015-02-19CS20150225000128
Cavazza Claudio (Passed away on 06/06/2011)
1.34亿 (L)
28.61% (L)
22.82%2011-06-16IS20110627000017
李燁妮 (董事)
1.29亿 (L)
21.83% (L)
21.83%2025-10-15DA20251020E00477
李燁妮
1.21亿 (L)
20.50% (L)
20.57%2017-09-15DA20170919000057
李小芳 (董事)
1.21亿 (L)
20.51% (L)
20.51%2024-06-20DA20251020E00485
李小芳
1.20亿 (L)
20.32% (L)
20.37%2017-04-13DA20170420000058
Assicurazioni Generali S.p.A
8,140.50万 (L)
13.80% (L)
13.82%2017-03-31CS20170407000136
Li Zhenfu
8,140.50万 (L)
13.80% (L)
13.82%2017-03-31IS20170406000138
Lion River I N.V.
8,140.50万 (L)
13.80% (L)
13.82%2017-03-31CS20170407000134
Cavazza Paolo
7,658.09万 (L)
13.01% (L)
13.01%2023-01-09IS20230112E00007
Paponi Claudia
7,658.09万 (L)
13.01% (L)
13.01%2023-01-09IS20230112E00004
李小羿 (董事)
6,339.23万 (L)
10.77% (L)
10.77%2025-10-15DA20251020E00487
呂淑冰
6,339.23万 (L)
10.77% (L)
10.77%2025-10-15IS20251020E00498
呂淑冰
5,946.23万 (L)
10.07% (L)
10.10%2017-07-20IS20170724000003
李小羿
5,946.23万 (L)
10.07% (L)
10.10%2017-07-20DA20170724000002
FMR LLC
5,903.24万 (L)
10.00% (L)
10.03%2017-06-20CS20170623000218
Cavazza Paolo
5,682.14万 (L)
9.63% (L)
9.65%2017-04-10IS20170411000071
Paponi Claudia
5,682.14万 (L)
9.63% (L)
9.65%2017-04-10IS20170411000072
Wu Sonny
3,933.99万 (L)
6.67% (L)
6.68%2017-04-19IS20170424000080
黄瑞瑨 (董事)
3,000.00万 (L)
5.09% (L)
5.09%2024-07-02DA20240705E00383
陳友正 (董事)
52.00万 (L)
0.09% (L)
0.09%2018-04-18DA20180419E00357
Ball Simon Miles (董事)
4.65万 (L)
0.01% (L)
0.008%2019-09-05DA20190917E00117